THBS1 and neoplasm: However, one of the most accepted consensuses includes doses ranging from one-tenth to one-third of the maximum tolerated dose and the sustained inhibition of tumor angiogenesis, which is detected as a minimal expression of VEGF and an increase in thrombospondin 1 (TSP-1) [8,9,10].